| Death | Myocardial Infarction | Heart Failure | Stroke | ||||
---|---|---|---|---|---|---|---|---|
 | No. Events (%) | Adjusted HR (95%CI)* n = 628 | No. Events (%) | Adjusted HR (95%CI)* n = 628 | No. Events (%) | Adjusted HR (95%CI)* n = 628 | No. Events (%) | Adjusted HR (95%CI)* n = 628 |
All Patients (n = 628) | Â | Â | Â | Â | Â | Â | Â | Â |
ADRB1 Arg389Gly | Â | Â | Â | Â | Â | Â | Â | Â |
Arg/Arg | 22 (7.3) | 1.00 (reference) | 4 (1.3) | 1.00 (reference) | 11 (3.6) | 1.00 (reference) | 14 (4.6) | 1.00 (reference) |
Arg/Gly | 29 (10.8) | 1.27 (0.73–2.23) | 13 (4.8) | 3.35 (1.08–10.3) | 16 (6.0) | 1.28 (0.58–2.80) | 9 (3.4) | 0.61 (0.26–1.41) |
Gly/Gly | 7 (13.0) | 1.65 (0.68–3.99) | 3 (5.6) | 3.89 (0.84–18.1) | 4 (7.4) | 2.12 (0.65–6.91) | 4 (7.4) | 1.53 (0.49–4.77) |
ADRB3 Trp64Arg †|  |  |  |  |  |  |  |  |
Trp/Trp | 50 (9.6) | 1.00 (reference) | 16 (3.1) | 1.00 (reference) | 24 (4.6) | 1.00 (reference) | 21 (4.0) | 1.00 (reference) |
Trp/Arg + Arg/Arg | 10 (9.7) | 1.01 (0.50–2.04) | 4 (3.9) | 1.47 (0.48–4.52) | 6 (5.8) | 1.46 (0.58–3.67) | 5 (4.8) | 1.20 (0.45–3.24) |
Non-obstructive CAD (n = 400) | Â | Â | Â | Â | Â | Â | Â | Â |
ADRB1 | Â | Â | Â | Â | Â | Â | Â | Â |
Arg389Gly | Â | Â | Â | Â | Â | Â | Â | Â |
Arg/Arg | 8 (4.1) | 1.00 (reference) | 0 | 1.00 (reference) | 3 (1.5) | 1.00 (reference) | 5 (2.6) | 1.00 (reference) |
Arg/Gly | 8 (4.8) | 0.77 (0.29–2.05) | 8 (4.8) | ... | 11 (6.6) | 4.37 (1.12–17.0) | 6 (3.6) | 1.06 (0.31–3.66) |
Gly/Gly | 4 (11.1) | 2.08 (0.60–7.18) | 2 (5.6) | ... | 0 | ... | 2 (5.6) | 1.54 (0.29–8.31) |
ADRB3 | Â | Â | Â | Â | Â | Â | Â | Â |
Trp64Arg †|  |  |  |  |  |  |  |  |
Trp/Trp | 17 (4.9) | 1.00 (reference) | 7 (2.1) | 1.00 (reference) | 11 (3.2) | 1.00 (reference) | 10 (2.9) | 1.00 (reference) |
Trp/Arg + Arg/Arg | 4 (6.9) | 1.91 (0.61–5.97) | 3 (5.2) | 2.94 (0.69–12.5) | 3 (5.2) | 2.10 (0.55–8.10) | 3 (5.2) | 2.35 (0.60–9.29) |